Phase 3 trial Archives

GENERAL Glenmark Specialty Advances Global Phase 3 Trial For Ovarian Cancer Drug

Glenmark Pharmaceuticals Ltd, through its wholly owned subsidiary Glenmark Specialty S.A., has advanced the Phase 3 clinical development of Trastuzumab rezetecan, a HER2-targeted antibody-drug conjugate (ADC), for the treatment of platinum-resistant ovarian cancer (PROC). India will become the first country across Glenmark’s licensed markets to initiate patient enrolment for the global Phase 3 clinical trial […]

CW Bureau · Jul 2, 2026

GENERAL CuraTeQ Biologics Reports Positive Phase 3 Results For BP11 Biosimilar

CuraTeQ Biologics Pvt Ltd, a wholly owned subsidiary of Aurobindo Pharma Ltd, has announced positive top-line results from its Phase 3 clinical study of BP11, an investigational biosimilar to Xolair (omalizumab). Study meets primary endpoints in CSU patients According to the company, the study successfully met all primary endpoints, demonstrating high comparability with the reference […]

CW Bureau · Apr 6, 2026